Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Point: should epidermal growth factor receptor mutations be routinely tested for in patients with lung cancer? Yes.

Chest - 1 Mar 2013

Sterman Daniel H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Non-Small-Cell Lung
Share to Diagnostic Tests, Routine
Share to Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erlotinib Hydrochloride

Share to Protein Kinase Inhibitors

Share to Protein-Tyrosine Kinases

Share to Quinazolines

Source

Identifiers

PMID: 23460149
DOI: 10.1378/chest.12-2546

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Point: should epidermal growth factor receptor mutations be routinely tested for in patients with lung cancer? Yes.PMID 23460149Read ↗

Counterpoint: should epidermal growth factor receptor mutations be routinely tested for in patients with lung cancer? No.Semantic proximity Read ↗

Epidermal Growth Factor Receptor Mutation Testing in Lung Cancer: Searching for the Ideal MethodSemantic proximity Read ↗

EGFR testing in lung cancer is ready for prime time.Semantic proximity Read ↗

[Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Pro].Semantic proximity Read ↗

[Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Contra].Semantic proximity Read ↗

The Frequency of Epidermal Growth Factor Receptor (EGFR) Mutation in Patients with Lung Cancer Referred to the Lung Diseases Hospital; A Cross Sectional StudySemantic proximity Read ↗

[Consensus for epidermal growth factor receptor gene mutation detection in non-small cell lung cancer].Semantic proximity Read ↗

[Molecular genetic tests in advanced non-small cell lung cancer: practical relevance].Semantic proximity Read ↗

ASCO Provisional Clinical Opinion: Epidermal Growth Factor Receptor Mutation Testing in PracticeSemantic proximity Read ↗

Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung CancersSemantic proximity Read ↗

Crossing the rubicon in lung adenocarcinoma: the conundrum of EGFR tyrosine kinase mutations.Semantic proximity Read ↗

Tyrosine kinase inhibitors and epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer: to test or not to test?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.